In this webinar, with Mark Uhlik from OncXerna Therapeutics – discover how the Xerna TME Panel was developed to understand the dominant biology of the tumor microenvironment and align to particular therapeutic modalities. Register Today.
The webinar will cover the following topics:
- An overview of the RNA-based Xerna TME Panel and its key biological features
- The development and validation of the Xerna TME Panel
- Potential clinical and research applications of the Xerna TME Panel to support multiple oncology therapeutics, particularly immune checkpoint inhibitors and anti-angiogenic agents, across a variety of tumor types
- Future development of the Xerna TME Panel as an RUO and CDx assay